References
- RECOMBINATE Prescribing Information
- Kingdon HS, Lundblad RL. An adventure in biotechnology: the development of haemophilia A therapeutics – from whole-blood transfusion to recombinant DNA to gene therapy. Biotechnol Appl Biochem. 2002;35(Pt 2):141-148.
- White GC II, Courter S, Bray GL, Lee M, Gomperts ED; and The Recombinate Previously Treated Patient Study Group. A multicenter study of recombinant factor VIII (Recombinate™) in previously treated patients with hemophilia A. Thromb Haemost. 1997;77(4):660-667.
- Bray GL, Gomperts ED, Courter S, et al; and the Recombinate Study Group. A multicenter study of recombinant factor VIII (Recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. Blood. 1994;83(9):2428-2435.